4 assets in Systolic Heart Failure

Therapeutic assets addressing Systolic Heart Failure, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Semaglutide Systolic Heart Failure	Jens D Hove, MD,PHD	P2/3	B (57)
Eplerenone Systolic Heart Failure	Karolinska Institutet	P2	CCC (50)
Ketone Monoester Systolic Heart Failure	The University of Texas Health Science Center at San Antonio	Early P1	C (39)
Dapagliflozin Systolic Heart Failure	National Medical Research Center for Cardiology, Ministry of Health of Russian Federation	N/A	D (30)